Asian Pacific Journal of Cancer Prevention

  • 제13권8호
  • /
  • Pages.3539-3548
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Targeting Tumor Metastasis by Regulating Nm23 Gene Expression

  • Prabhu, V. Vinod (Department of Biotechnology, Karunya University) ;
  • Siddikuzzaman, Siddikuzzaman (Department of Biotechnology, Karunya University) ;
  • Grace, V.M. Berlin (Department of Biotechnology, Karunya University) ;
  • Guruvayoorappan, C. (Department of Biotechnology, Karunya University)
  • 발행 : 2012.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The Nm23 gene is a metastatic suppressor identified in a melanoma cell line and expressed in different tumors where their levels of expression are associated with reduced or increased metastatic potential. Nm23 is one of the over 20 metastasis suppressor genes (MSGs) confirmed in vivo. It is highly conserved from yeast to human, implying a critical developmental function. Tumors with alteration of the p53 gene and reduced expression of the Nm23 gene are more prone to metastasis. Nm23-H1 has 3'-5' exonuclease activity. This review focuses on the role of Nm23 in cancer progression and also a potential novel target for cancer therapy.

키워드

참고문헌

  1. Adams DG, Coffee RL, Zhang H, et al (2005). Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/ threonine phosphatase 2A holoenzymes. J Biol Chem, 30, 42644-54.
  2. Almgren MA, Henriksson KC, Fujimoto J, Chang CL (2004). Nucleoside diphosphate kinase A/nm23-H1 promotes metastasis of NB69-derived human neuroblastoma. Mol Cancer Res, 2, 387-94.
  3. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, et al (1993). Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene, 8, 497-502.
  4. Boissan M, De Wever O, Lizarraga F, et al (2010). Implication of metastasis suppressor nm23-h1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res, 70, 7710.
  5. Boissan M, Wendum D, Arnaud-Dabernat S, (2005) . Increased lung metastasis in transgenic NM23-Null/SV40 micewith hepatocellular carcinoma. J Natl Cancer Inst, 97, 836-45. https://doi.org/10.1093/jnci/dji143
  6. Branca M, Giorgi C, Ciotti M (2006). Down-regulated nucleoside diphosphate kinase nm23-1 expression is unrelated to highrisk human papillomavirus but associated with progression of cervical intraepithelialneoplasia and unfavourable prognosis in cervical cancer. J Clin Pathol, 59, 1044-51. https://doi.org/10.1136/jcp.2005.033142
  7. Buxton IL, Yokdang N, Matz RM (2010). Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis. Cancer Lett, 28, 131-41.
  8. Buxton ILO, Yokdang N (2011). Extracellular NM23 Signaling in breast cancer: incommodus verum. Cancers, 3, 2844-57 https://doi.org/10.3390/cancers3032844
  9. Carinci F, Arcelli D, Lo Muzio L, et al (2007). Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma. Transl Res, 150, 233-45. https://doi.org/10.1016/j.trsl.2007.03.011
  10. Chambers AF, Naumov GN, Vantyghem SA, Tuck AB (2000). Molecular biology of breast cancer metastasis: clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res, 2, 400-7. https://doi.org/10.1186/bcr86
  11. Chambers A, Groom A, MacDonald I (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Cancer Rev, 2, 563-72. https://doi.org/10.1038/nrc865
  12. Chin-Shiu H, Ming-Kuei S, Cheng-Hung C, Miao-Lin H (2005). Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma SK-Hep-1 cells. J Nutr, 135, 2119-23. https://doi.org/10.1093/jn/135.9.2119
  13. Choi YJ, Cho SK, Hwang KC, et al (2009). Nm23-M5 mediates round and elongated spermatid survival by regulating GPX-5 levels. FEBS Lett, 17, 1292-8.
  14. De La Rosa A, Williams RL, Steeg PS (1995). Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays, 17, 53-62. https://doi.org/10.1002/bies.950170111
  15. Desvignes T, Pontarotti P, Fauvel C, Bobe J (2009). Nme protein family evolutionary history, a vertebrate perspective. BMC Evol Biol, 9, 256.
  16. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J (2003). The tumor metastasis suppressor NM23-H1 is a granzyme A-activated DNase that nicks DNA during CTL-mediated apoptosis and the nucleosome assembly protein SET is its inhibitor. Cell, 112, 659-72. https://doi.org/10.1016/S0092-8674(03)00150-8
  17. Filiz G, Adim S, Aytacm B, Akar E, Vuruskan H (2010). Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma. J Int Med Res, 38, 620-4. https://doi.org/10.1177/147323001003800224
  18. Fournier HN, Albiges-Rizo C, Block MR (2003). New insights into Nm23 control of cell adhesion and migration. J Bioenerg Biomembr, 35, 81-7. https://doi.org/10.1023/A:1023450008347
  19. Fuhrman B, Volkova N, Rosenblat M, Aviram M (2000). Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal, 2, 491-506. https://doi.org/10.1089/15230860050192279
  20. Gallagher BC, Parrott KA, Szabo G, De S Otero A (2003). Receptor activation regulatescortical, but not vesicular localization of NDP kinase. J Cell Sci, 116, 3239-50. https://doi.org/10.1242/jcs.00630
  21. Gupta GP, Massague J (2006). Cancer metastasis: building a framework. Cell, 127, 679-95. https://doi.org/10.1016/j.cell.2006.11.001
  22. Hamby CV, Abbi R, Prasad N, et al (2000). Backer Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Int J Cancer, 15, 547-53.
  23. Hartsough MT, Clare SE, Mair M, et al (2001). Elevation of Breast Carcinoma Nm23-H1 Metastasis Suppressor Gene Expression and Reduced Motility by DNA Methylation Inhibition. Cancer Res, 61, 2320-7.
  24. Howlett AR, Petersen OW, Steeg PS, Bissell MJ (2010). Novel function for the nm23-Hl gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. LBNL, 86, 1838-44.
  25. Ikeda T (2010). NDP kinase 7 is a conserved microtubule-binding protein preferentially expressed in ciliated cells. Cell Struct Funct, 13, 23-30.
  26. Ishikawa N, Shimada N, Takagi Y, et al (2003). Molecular evolution of nucleoside diphosphate kinase genes: conserved core structures and multiple-layered regulatory regions. J Bioenerg. Biomembr, 35, 7-18. https://doi.org/10.1023/A:1023433504713
  27. Iwashita S, Fujii M, Mukai H, Ono Y, Miyamoto M (2004). Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2. Biochem Biophys Res Commun, 6, 1063-8.
  28. Jung H, Seong HA, Ha H (2007). NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function. J Biol Chem, 30, 35293-307.
  29. Kaetzel DM (2003). Transcription of the platelet-derived growth factor a-chain gene. Cytokine Growth Factor Rev, 14, 427-46. https://doi.org/10.1016/S1359-6101(03)00051-0
  30. Kaetzel DM, McCorkle JR, Novak M, Yang M, Jrrett, SG (2009). Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1. Mol Cell Biochem, 329, 161-5. https://doi.org/10.1007/s11010-009-0108-3
  31. Kapoor S (2009). Nm23H1 expression and its role in the evolution of non-gastrointestinal malignancies. World J Gastroenterol, 28, 506-7.
  32. Khan MH, Yasuda M, Higashino F, et al (2001). nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol, 158, 1785-91. https://doi.org/10.1016/S0002-9440(10)64134-X
  33. Kimura N, Shimada N, Fukuda M, et al (2000). Regulation of cellular functions by nucleoside diphosphate kinases in mammals. J Bioenerg Biomembr, 32, 309-15. https://doi.org/10.1023/A:1005549315846
  34. Krishnan KS, Rikhy R, Rao R, et al (2001). Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron, 30, 197-210. https://doi.org/10.1016/S0896-6273(01)00273-2
  35. Kuppers DA, Lan K, Knight JS, Robertson ES (2005). Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. J Virol, 79, 9714-24. https://doi.org/10.1128/JVI.79.15.9714-9724.2005
  36. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000). The humanNm23/nucleosidediphosphate kinases. J Bioenerg Biomembr, 32, 247-58. https://doi.org/10.1023/A:1005584929050
  37. Lee JH, Marshall JC, Steeg PS, Horak CE (2009). Altered gene and protein expression by Nm23-H1 in metastasis suppression. Mol Cell Biochem, 329, 141-8. https://doi.org/10.1007/s11010-009-0124-3
  38. Lee MY, Jeong EJ, Oh JW, Choi KY (2009). NM23H2 inhibits EGF- and Ras-induced proliferation of NIH3T3 cells by blocking the ERK pathway. Cancer Lett, 18, 221-6.
  39. Levit MN, Abramczyk BM, Stock JB, Postel EH (2002). Interactions between Escherichia coli Nucleosidediphosphate Kinase and DNA. J Biol Chem, 277, 5163-7. https://doi.org/10.1074/jbc.M111170200
  40. Li Y, Nie CJ, Hu L, et al (2010). Characterization of a novel mechanism of genomic instability involving the SEI1/SET/ NM23H1 pathway in esophageal cancers. Cancer Res, 15, 5695-705.
  41. Li L, Chen LZ (2012). Factors influencing axillary lymph node metastasis in invasive breast cancer. Asian Pac J Cancer Prev, 13, 251-4. https://doi.org/10.7314/APJCP.2012.13.1.251
  42. Li Z, Xiang J, Zhang W, et al (2009). Nanoparticle delivery of antimetastatic NM23-H1 gene improves chemotherapy in a mouse tumor model. Cancer Gene Ther, 16, 423-9. https://doi.org/10.1038/cgt.2008.97
  43. Li J, Zhou J, Chen G, et al (2006) Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. Cancer Gene Ther, 13, 266-72. https://doi.org/10.1038/sj.cgt.7700899
  44. Lin KH, Wang WJ, Wu YH, Cheng SY (2002). Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor. Endocrinology, 143, 467-75. https://doi.org/10.1210/en.143.2.467
  45. Liu F, Zhang Y, Zhang XY, Chen HL (2002). Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha1,3 fucosyltransferase VII, and metalloproteinase-2 and matrix metallopoproteinase-9 expression. J Cancer Res Clin Oncol, 128, 189-96. https://doi.org/10.1007/s00432-001-0314-1
  46. Lizuka N, Miyamoto K, Tangoku A, et al (2000).Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with $Na(^{+})$, $K(^{+})$-ATPase. Br J Cancer, 83, 1209-15. https://doi.org/10.1054/bjoc.2000.1436
  47. Ma D, Xing Z, Liu B, et al (2002). NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem, 277, 1560-7. https://doi.org/10.1074/jbc.M108359200
  48. MacDonald NJ, De La Rosa A, Benedict MA, et al (1993). A serine phosphorylation of nm23, and not its nucleoside disphosphat e kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem, 268, 25780-9.
  49. Marshall JC, Collins J, Marino N, Steeg P (2010). The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer, 46, 1278-82. https://doi.org/10.1016/j.ejca.2010.02.042
  50. Marshall JC, Lee JH, Steeg PS (2009). Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression. Mol Cell Biochem, 329, 115-20. https://doi.org/10.1007/s11010-009-0116-3
  51. Marino N, Nakayama J, Collins JW, Steeg PS (2012). Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene. Cancer Metastasis Rev. Jun 16. DOI 10.1007/s10555-012-9374-8. [Epub ahead of print].
  52. Mathieu B, Dominique W, Arnaud-Dabernat S, et al (2005). increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. J Natl Cancer Inst, 97, 836-45. https://doi.org/10.1093/jnci/dji143
  53. McDermott WG, Boissan M, Lacombe ML, Steeg PS, Horak CE (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin Exp Metastasis, 25, 131-8. https://doi.org/10.1007/s10585-007-9128-0
  54. Milon L, Meyer P, Chiadmi M, et al (2000). The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase. J Biol Chem, 12, 14264-72.
  55. Mona A, Kandil MD, Monshira M, ABD El-Wahed MD (2000). The significance of metastasis related-factor nm23-Hi and cathepsin D in prostrate cancer. J Egyptian Nat Cancer Inst, 12, 199-210.
  56. Munier A, Serres C, Kann ML, et al (2003). Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility? Exp Cell Res, 1, 295-306.
  57. Nakazawa Y, Arai H, Fujita N (2011). The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis. Cancer Res, 71, 1146-55. https://doi.org/10.1158/0008-5472.CAN-10-2695
  58. Narayanan R, Ramaswami M (2003). Regulation of dynamin by nucleoside diphosphate kinase. J Bioenerg Biomembr, 35, 49-55. https://doi.org/10.1023/A:1023441806530
  59. Negroni A, Venturelli D, Tanno B, et al (2000). Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Cell Death Differ, 7, 843-50. https://doi.org/10.1038/sj.cdd.4400720
  60. Otero AS (2000). NM23/nucleoside diphosphate kinase and signal transduction. J Bioenerg Biomembr, 32, 269-75. https://doi.org/10.1023/A:1005589029959
  61. Otsuki Y, Tanaka M, Yoshii S, et al (2001). Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci USA, 98, 4385-90. https://doi.org/10.1073/pnas.071411598
  62. Ouatas T, Halverson D, Steeg PS (2003). Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clin Cancer Res, 9, 3763-72.
  63. Palmieri D, Halverson DO, Ouatas T, et al (2005). Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptornegative breast cancer. J Natl Cancer Inst, 97, 632-42. https://doi.org/10.1093/jnci/dji111
  64. Parhar RS, Shi Y, Zou M, et al (1995). Effects of cytokine mediated modulation of Nm23 expression on the invasion and metastatic behavior of B16FlO melanoma cells. Int J Cancer, 60, 204-10.
  65. Park HR, Kim SH, Lee SY, et al (2010). Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer, 117, 1864-73.
  66. Postel EH, Berberich SJ, Rooney JW, Kaetzel DM (2000). Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr, 32, 277-84. https://doi.org/10.1023/A:1005541114029
  67. Postel EH, Zou X, Notterman DA, La Perle KM (2009). Double knockout Nme1/Nme2 mouse model suggests a critical role for NDP kinases in erythroid development. Mol Cell Biochem, 329, 45-50. https://doi.org/10.1007/s11010-009-0110-9
  68. Raftopoulou M, Hall A (2004). Cell migration: Rho GTPases lead the way. Dev Biol, 265, 23-32. https://doi.org/10.1016/j.ydbio.2003.06.003
  69. Rinker-Schaeffer JP, Keefe DR, Welch D (2006). Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clin Cancer Res, 13, 3882-9.
  70. Roberts PJ, Der CJ (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 14, 3291-310.
  71. Roymans D, Vissenberg K, De Jonghe C, et al (2001). Identification of the tumor metastasis suppressor Nm23-H1/ Nm23-R1 as a constituent of the centrosome. Exp Cell Res, 15, 145-53.
  72. Sadek CM, Damdimopoulos AE, Pelto-Huikko M, et al (2001). Sptrx-2, a fusion protein composed of one thioredoxin and three tandemly repeated NDP-kinase domains is expressed in human testis germ cells. Genes Cells, 6, 1077-90. https://doi.org/10.1046/j.1365-2443.2001.00484.x
  73. Seong HA, Jung H, Ha H (2007). NM23-H1 tumor suppressor physically interacts with serine-threonine kinase receptorassociated protein, a transforming growth factor-beta (TGFbeta) receptor-interacting protein, and negatively regulates TGF-beta signaling. J Biol Chem, 282, 12075-96. https://doi.org/10.1074/jbc.M609832200
  74. She S, Xu B, He M, Lan X, Wang Q (2010). Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1. J Exp Clin Cancer Res, 11, 29-93.
  75. Siclari VA, Guise TA, Chirgwin JM (2006). Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer metastasis Rev, 25, 621-33.
  76. Siddikuzzaman, Grace VM, Guruvayoorappan C (2011). Lysyl oxidase: a potential target for cancer therapy. Inflammopharmacology, 19, 117-29. https://doi.org/10.1007/s10787-010-0073-1
  77. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (2002). Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA, 3, 11593-8.
  78. Sies H, Stahl W (2003). Non-nutritive bioactive constituents of plants: lycopene, lutein and zeaxanthin. Int J Vitam Nutr Res, 73, 95-100. https://doi.org/10.1024/0300-9831.73.2.95
  79. Simonsson T, Pribylova M, Vorlickova M (2000). A nuclease hypersensitive element in the human c-myc promoter adopts several distinct i-tetraplex structures. Biochem Biophys Res Commun, 11,158-66.
  80. Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, et al (2005). Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Exp Mol Pathol, 79, 42-50. https://doi.org/10.1016/j.yexmp.2005.02.004
  81. Sossey-Alaoui K, Safina A, Li X, et al (2007). Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol, 170, 2112-21. https://doi.org/10.2353/ajpath.2007.060975
  82. Sporn MB (1996). The war on cancer. Lancet, 347, 1377-81. https://doi.org/10.1016/S0140-6736(96)91015-6
  83. Stafford LJ, Vaidya KS, Welch DR (2008). Metastasis suppressors genes in cancer. Int J Biochem Cell Biol, 40, 874-91. https://doi.org/10.1016/j.biocel.2007.12.016
  84. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JB et al (1988). Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst, 24, 200-4.
  85. Steeg PS (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med, 12, 895-904. https://doi.org/10.1038/nm1469
  86. Steeg PS, Horak CE, Miller KD (2008). Clinical-translational approaches to the Nm23-H1 metastasis suppressor. Clin Cancer Res, 14, 5006-12. https://doi.org/10.1158/1078-0432.CCR-08-0238
  87. Steeg P (2003). Metastasis suppressors alter the signal transduction of cancer cells. Nat Cancer Rev, 3, 55-63. https://doi.org/10.1038/nrc967
  88. Syed V, Mukherjee K, Lyons-Weiler J, et al (2005). Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene, 3, 1774-87.
  89. Tagashira H, Hamazaki K, Tanaka N, Gao C, Namba M (1998). Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (colon 26 line) transfected with nm23-2 rat nucleoside diphosphate kinase a isoform. Int J Mol Med, 2, 65-8.
  90. Thakur RK, Kumar PL, Halder K, et al (2009). Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res, 37, 172-83. https://doi.org/10.1093/nar/gkn919
  91. Tomita M, Ayabe T, Matsuzaki Y, Onitsuka T (2001). Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients. Eur J Cardiothorac Surg, 19, 904-7. https://doi.org/10.1016/S1010-7940(01)00710-2
  92. Townson JL, Chambers AF (2006). Dormancy of solitary metastatic cells. Cell Cycle, 5, 1744-50. https://doi.org/10.4161/cc.5.16.2864
  93. Tsuiki H, Nitta M, Furuya A, et al (1999). A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis. J Cell Biochem, 76, 254-69.
  94. Valentijn LJ, Koster J, Versteeg R (2006). Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Genomics, 87, 483-9. https://doi.org/10.1016/j.ygeno.2005.11.004
  95. Venturelli D, Cesi V, Ransac S, et al (2000). The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells. Exp Cell Res, 15, 265-71.
  96. Wagner PD, Steeg PS, Vu ND (1997). Two-component kinaselike activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci USA, 94, 9000-5. https://doi.org/10.1073/pnas.94.17.9000
  97. Wang YF, Chow KC, Chang SY (2004). Prognostic significance of nm23-1 expression in oral squamous cell carcinoma. Br J Cancer, 90, 2186-93. https://doi.org/10.1038/sj.bjc.6601808
  98. Wang HM, Wang J (2012). Expression of Tiam1 in lung cancer and its clinical significance. Asian Pac J Cancer Prev, 13, 613-5. https://doi.org/10.7314/APJCP.2012.13.2.613
  99. Webb PA, Perisic O, Mendola CE, Backer JM, Williams RL (1995). The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. J Mol Biol, 25, 574-87.
  100. Yu LG, Packman LC, Weldon M, Hamlett J, Rhodes JM (2004). Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the anti-proliferative lectin. Jacalin J Biol Chem, 1, 41377-83.
  101. Zajac-Kaye M (2001). Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer, 34, 43-6. https://doi.org/10.1016/S0169-5002(01)00343-9
  102. Zhang Q, McCorkle JR, Novak M, et al (2011). Metastasis suppressor function of NM23-H1 requires its 30-50 exonuclease activity. Int J Cancer, 128, 40-50. https://doi.org/10.1002/ijc.25307
  103. Ziaei JE, Pourzand A, Bayat A, Vaez J (2012). Patterns of metastasis and survival in breast cancer patients: a preliminary study in an Iranian population. Asian Pac J Cancer Prev, 13, 937-40. https://doi.org/10.7314/APJCP.2012.13.3.937

피인용 문헌

  1. Kisspeptins (KiSS-1): Essential Players in Suppressing Tumor Metastasis vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6215
  2. Inhibition of Metastatic Lung Cancer in C57BL/6 Mice by Marine Mangrove Rhizophora apiculata vol.14, pp.3, 2013, https://doi.org/10.7314/APJCP.2013.14.3.1833
  3. Putative biomarkers and therapeutic targets associated with radiation resistance vol.11, pp.2, 2014, https://doi.org/10.1586/14789450.2014.893194
  4. cabinet of curiosities: the microbium, the host and cancer association vol.29, pp.2, 2014, https://doi.org/10.1111/omi.12047
  5. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study vol.11, pp.6, 2015, https://doi.org/10.1039/C5MB00076A
  6. RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch vol.34, pp.17, 2015, https://doi.org/10.1038/onc.2014.175